Ligand Pharmaceuticals Incorporated (LGND)

Last Closing Price: 201.90 (2026-03-06)

Loss Ratio (Quarterly)

Loss Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The loss ratio is calculated by taking the incurred underwriting losses and then dividing them by earned premium. Calculated as: Underwriting Losses Total / Net Premiums Earned

Ligand Pharmaceuticals Incorporated (LGND) Loss Ratio data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
$59.67M
$44.78M
$2.99M
$56.67M
$45.82M
$13.84M
$42.94M
$56.78M
$34.72M
$44.78M
$44.78M
$44.78M
$18.67M
$13.84M
$20.61M
19.34M
20.29M
$2.41
$2.42
Balance Sheet Financials
$832.27M
--
$728.37M
$1.56B
$37.45M
$446.19M
$505.98M
$543.42M
$1.02B
$690.23M
$1.02B
19.77M
Cash Flow Statement Financials
$49.36M
$-377.32M
$428.22M
$72.31M
$174.93M
$102.62M
$46.85M
--
--
Fundamental Metrics & Ratios
22.23
--
--
0.30
0.44
94.99%
23.20%
23.20%
--
95.16%
75.06%
$38.05M
Loss Ratio
--
--
--
0.04
0.33
0.98
92.08
4.40%
6.49%
2.87%
3.06%
$51.44
$1.87
$2.43